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We report herein the draft genomes of five novel Escherichia coli strains isolated from surveillance and experimental mice
housed at MIT and theWhitehead Institute and describe their genomic characteristics in context with the polyketide synthetase
(PKS)-containing pathogenic E. coli strains NC101, IHE3034, and A192PP.
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Escherichia coli is typically considered a harmless commensalbacteria colonizing the mammalian intestine. However, infec-
tion by numerous strains from the B2 phylogroup can cause sep-
ticemia/bacteremia, urinary tract infection, and meningitis and
are increasingly being linked to inflammatory bowel disease and
colorectal tumors in humans (1–3). These strains commonly har-
bor an ~54-kb polyketide synthetase (PKS) pathogenicity island
that produces a genotoxin called colibactin (4, 5). Recently, coli-
bactin expression by the mouse commensal E. coli strain NC101
was shown to potentiate colitis-associated colorectal cancer in
IL-10/ mice (2). Furthermore, aside from causing double-
strand DNA breaks, colibactin facilitates intestinal colonization
and systemic translocation that causes septicemia and meningitis
(6). Thus, the virulence and oncogenic modalities of colibactin-
producing E. coli strains in experimental mice may represent a
potential confounder of results, especially inmodels of inflamma-
tory disease and cancer.
In this report, we announce the draft genomes of five novel
B2-phylotype E. coli strains isolated from the feces of two asymp-
tomatic surveillancemice, the uterine fluid of a transgenic mouse,
and from the blood of two experimental immunocompromised
mice with sepsis housed under specific-pathogen-free conditions.
We previously found all these strains except A4were PCR-positive
for the PKS genes clbA and clbQ and caused megalocytosis and
-H2AX-detectable DNA damage in HeLa cells in vitro, suggest-
ing colibactin activity by these organisms ([7]; our unpublished
data). We briefly describe the features of these novel E. coli ge-
nomes in context to the previously sequenced genomes of NC101
and the PKS-containing septicemia- and meningitis-causing
strains IHE3034 and A192PP (4, 6).
Genomes were sequenced using PacBio RSII and resulting se-
quencing data were assembled into two to five contigs using RS_
HGAP_Assembly.3 from the SMRTPortal 2.3. Contigs were anno-
tated using the RAST tool kit (RASTtk) (8). Novel strains have
genomic sizes, GC content, protein-coding sequences, and
RNAs comparable to those of the genomes of NC101 (GenBank:
NZ_AEFA00000000.1), IHE3034 (GenBank: NC_017628.1), and
A192PP (GenBank: NZ_CVOH00000000.1) (Table 1). All novel
genomes except A4 contained complete PKS islands, with all genes
having99% sequence identity and coverage as well as identical
synteny to those from NC101, IHE3034, and A192PP.
PATRIC’s proteome comparison service was used to determine
the number of homologous genes between NC101, IHE3034, and
A192PP as references versus the novel E. coli strains (9). NC101
and the novel PKS-containing strains shared 4,780 proteins
(97%) as homologs, whereas between NC101 and A4, 4,732
proteins (~89%) were homologous. All novel E. coli strain shared
considerably less homologs to IHE3034 (4,386 to 4,525 proteins;
~87 to 90%) and A192PP (4,472 to 4,624; ~80 to 83%).
Aside from PKS, the virulence factors enterobactin sidero-


















E. coli 1409150006 (MIT A2) MBNU00000000 Feces 5,292,961 3 114.7 50.5 5,203 108
E. coli 1409160003 (MIT A4) MBNV00000000 Feces 5,066,411 4 166.4 50.5 5,003 114
E. coli 1408270010 (MIT A21) MBNW00000000 Uterine fluid 5,318,023 5 129.9 50.5 5,280 108
E. coli 1512290008
(Whitehead Institute 0008)
MBNX00000000 Blood 5,289,663 3 147.7 50.5 5,203 108
E. coli 1512290026
(Whitehead Institute 0026)
MBNY00000000 Blood 5,005,444 2 140.6 50.6 4,876 108
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phore receptor protein, s-fimbriae minor subunit, glutamate de-
carboxylase, per-activated serine protease autotransporter entero-
toxin, and bor protein precursor were identified inNC101 and the
novel PKS-containing strains using VirulenceFinder 1.5 (10). A4
also contained glutamate decarboxylase, per-activated serine pro-
tease autotransporter enterotoxin, and bor protein precursor as
well as serine protease autotransporters of Enterobacteriaceae.
Together, these genomic data suggest that the novel PKS-
containing strains are more similar to NC101 than IHE3034 and
A192PP. Future studies will investigate the pathogenic and carci-
nogenic potential of these and other PKS-containing E. coli strains
in mice under differing experimental protocols.
Accession number(s). The genome sequences have been sub-
mitted to GenBank under the accession numbers listed in Table 1.
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